Advertisement

Topics

AI for drug discovery will be driven by biopharma and the rise of Asian tigers, says Insilico CEO

10:01 EDT 17 Apr 2019 | Outsourcing-Pharma

China-based pharmaceutical companies betting big and small biopharma able to quickly innovate will drive the use of AI for drug discovery â a market some analysts predict will reach a valuation of $20bn by 2024.

Original Article: AI for drug discovery will be driven by biopharma and the rise of Asian tigers, says Insilico CEO

NEXT ARTICLE

More From BioPortfolio on "AI for drug discovery will be driven by biopharma and the rise of Asian tigers, says Insilico CEO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...